Valeant Pharma ($VRX) announced that its Chairman and CEO Michael Pearson will be on medical leave of absence, effectively, following him being treated for a severe case of Pneumonia. The company said it has created an office of the CEO, including its General Counsel, Group Chairman and CFO, to serve in an interim capacity.
(0)
(0)